Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tretinoin topical - Avecho Biotechnology

Next Previous
Search
Drug Profile

Tretinoin topical - Avecho Biotechnology

Alternative Names: Retinoic acid topical; TPM-02/retinoic acid; TPM®/tretinoin; Tretinoin/TPM®

Latest Information Update: 02 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Phosphagenics
  • Developer Avecho Biotechnology
  • Class Antiacnes; Antineoplastics; Cyclohexenes; Keratolytics; Retinoids; Small molecules
  • Mechanism of Action Protein synthesis inhibitors; Retinoic acid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Acne vulgaris

Highest Development Phases

  • Phase II Acne vulgaris

Most Recent Events

  • 21 Aug 2019 Tretinoin topical is still in phase I/II development for Acne vulgaris in Australia and New Zealand (Phosphagenics pipeline, August 2019)
  • 30 May 2016 Tretinoin topical - Phosphagenics is available for licensing in World as of 30 May 2016. http://www.phosphagenics.com
  • 08 Oct 2014 Phosphagenics completes a phase II trial in Acne vulgaris in Australia and New Zealand (Topical) (ACTRN12613000756729)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top